信测标准(300938) - 2023 Q1 - 季度财报
EMTEKEMTEK(SZ:300938)2023-04-27 16:00

Financial Performance - The company's revenue for Q1 2023 was ¥150,412,635.18, representing a 30.69% increase compared to ¥115,093,706.41 in the same period last year[5] - Net profit attributable to shareholders was ¥31,481,270.57, up 40.69% from ¥22,377,006.12 year-on-year[5] - Basic earnings per share rose to ¥0.2845, a 44.27% increase from ¥0.1972 in the same period last year[5] - The net increase in cash and cash equivalents was ¥47,424,249.51, reflecting a 640.58% rise from ¥6,403,691.27 in the same period last year[9] - The net profit for Q1 2023 reached CNY 34,403,384.90, up 50.8% from CNY 22,839,235.93 in Q1 2022[19] - The operating profit for the current period was CNY 39,645,054.35, an increase of 48.8% compared to CNY 26,643,314.77 in the previous year[19] Cash Flow - The net cash flow from operating activities increased by 42.30% to ¥29,781,326.30, compared to ¥20,928,814.72 in the previous year[5] - The net cash flow from operating activities was CNY 29,781,326.30, which is a 42.3% increase from CNY 20,928,814.72 in the same quarter last year[21] - The net cash flow from investment activities was 32,122,667.06 CNY, compared to a negative cash flow of 9,411,841.78 CNY in the previous period[22] - The net cash flow from financing activities was -14,394,651.50 CNY, a decline from -5,088,375.40 CNY in the previous period[22] - The cash inflow from financing activities was 750,000.00 CNY, all from minority shareholders' investments[22] - The cash outflow for debt repayment was 8,000,000.00 CNY, indicating ongoing financial obligations[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,494,604,648.12, a 1.54% increase from ¥1,471,901,040.15 at the end of the previous year[5] - The total current liabilities decreased to CNY 176,928,713.89 from CNY 189,441,786.65, a reduction of approximately 6.7%[15] - The company's total liabilities decreased to CNY 260,890,246.44 from CNY 278,519,458.65, a decline of approximately 6.3%[15] - The total equity attributable to shareholders increased by 3.32% to ¥1,163,875,628.82 from ¥1,126,464,922.97 at the end of the previous year[5] - The total equity attributable to shareholders of the parent company increased to CNY 1,163,875,628.82, up from CNY 1,126,464,922.97[16] Inventory and Receivables - Accounts receivable rose to CNY 217,359,878.84, up from CNY 190,733,998.23, indicating an increase of about 13.9%[14] - The inventory balance increased to CNY 55,270,128.86 from CNY 51,700,426.32, representing an increase of about 6.5%[14] Research and Development - Research and development expenses for the quarter were CNY 12,995,897.97, an increase of 22.5% from CNY 10,603,620.31 in the previous year[17] Other Information - The company had a total of 5,679 ordinary shareholders at the end of the reporting period[11] - There are no new product developments or market expansion strategies mentioned in the provided documents[13] - The company's first-quarter report was not audited[23]